Zura Bio(DE:94E)
€1.12-0.14 (-11.11%)
DE:94E
Zura Bio ownership
€1.12
At close:-0.14 (-11.11%)
Zura Bio (94E) Ownership - Who Owns Zura Bio?
3 Followers
Zura Bio (94E) Ownership Overview
- 8.13% Insiders
- 3.63% Mutual Funds
- 10.44% Other Institutional Investors
- 4.26% ETFs
- 73.55% Public Companies and Individual Investors
The ownership structure of Zura Bio (DE:94E) stock is a mix of institutional, retail, and individual investors. Approximately 18.32% of the company’s stock is owned by Institutional Investors, 8.13% is owned by Insiders, and 73.55% is owned by Public Companies and Individual Investors.
The ownership structure of Zura Bio (DE:94E) stock is a mix of institutional, retail, and individual investors. Approximately 18.32% of the company’s stock is owned by Institutional Investors, 8.13% is owned by Insiders, and 73.55% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Mar 01, 2026 | Ai Biotechnology Llc | $12,500,000 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Ai Biotechnology Llc | 6,552,725 | Insider | 6.80% | 8,086,063 |
| BlackRock, Inc. | 3,699,932 | Institution | 3.84% | 4,565,716 |
| Ishares | 2,265,384 | Institution | 2.35% | 2,795,484 |
| Vanguard | 1,111,079 | Institution | 1.15% | 1,371,071 |
| Amit Munshi | 777,384 | Insider | 0.81% | 959,292 |
| Vanguard Index Funds | 747,352 | Institution | 0.78% | 922,232 |
| Fidelity Salem Street Trust | 701,029 | Institution | 0.73% | 865,070 |
| Fidelity Concord Street Trust | 585,887 | Institution | 0.61% | 722,985 |
| Fidelity Select Portfolios | 509,657 | Institution | 0.53% | 628,917 |
| Kim Davis | 493,881 | Insider | 0.51% | 609,449 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 747,352 | Institution | 0.78% | 922,232 |
| Fidelity Salem Street Trust | 701,029 | Institution | 0.73% | 865,070 |
| Fidelity Concord Street Trust | 585,887 | Institution | 0.61% | 722,985 |
| Fidelity Select Portfolios | 509,657 | Institution | 0.53% | 628,917 |
| Vanguard Scottsdale Funds | 406,788 | Institution | 0.42% | 501,976 |
| Schwab Capital Trust | 174,395 | Institution | 0.18% | 215,203 |
| Tiaa-cref Funds | 102,121 | Institution | 0.11% | 126,017 |
| Bridgeway Funds, Inc. | 85,348 | Institution | 0.09% | 105,319 |
| Goldman Sachs Trust | 33,570 | Institution | 0.03% | 41,425 |
| Russell Investment Co | 32,726 | Institution | 0.03% | 40,384 |
FAQ
Who Owns Zura Bio (DE:94E)?
According to the latest TipRanks data, approximately 18.32% of the company's stock is held by institutional investors, 8.13% is held by insiders, and 73.55% is held by public companies and individual investors.
What percentage of Zura Bio (DE:94E) stock is held by institutional investors?
According to the latest TipRanks data, approximately 18.32% of Zura Bio (DE:94E) stock is held by institutional investors: 3.63% by mutual funds, 4.26% by ETFs and 10.44% by other institutional investors.
What percentage of Zura Bio (DE:94E) stock is held by retail investors?
According to the latest TipRanks data, approximately 73.55% of Zura Bio (DE:94E) stock is held by public companies and individual investors.
Who owns the most shares of Zura Bio (DE:94E)?
AI Biotechnology LLC owns the most shares of Zura Bio (DE:94E).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

